Device Trial Radar · NCT06590272
Comparison on Outcomes of Four IOLs in Patients With Cataracts
Last checked: Nov 20, 2026Latest source record: Sep 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
103
Actual
Start
Oct 1, 2021
Primary completion
Jun 30, 2023
Study completion Jun 30, 2023
Sponsor
- Lead sponsor
- Shanghai 10th People's HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Sep 19, 2024
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 50 years, up to 95 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study was to compare the objective visual outcomes and subjective fuctional vision of four different intraocular lens (IOL) in patients underwent cataracts surgery. This was a retrospective study. Patients with age-related cataract underwent phacoemulsification combined with IOLs implantation. Patients were divided into 4 groups. Uncorrected distant visual acuity(UDVA), uncorrected intermediate visual acuity (UIVA), uncorrected near visual acuity (UNVA),and the best corrected visual acuity (BCVA) 1 month and 3 months after the surgery were determined. The defocus curve, contrast sensitivity, and customized VF-14-oriented Visual Function Index questionnaire were performed 3 months postoperatively. Kruskal-Wallis test and generalized estimating equation(GEE) were used to analyze and compare the difference between objective visual outcomes and subjective visual quality among different groups.
Conditions
- Cataract
- Intraocular Lens
- Visual Outcomes
Interventions
TECNIS PCB00 intraocular lensDevice
In this study, we select TECNIS PCB00 IOL for inserting in the eyes during the cataract surgery
HumanOptics Diff-Aay intraocular lensDevice
In this study, we select HumanOptics Diff-Aay IOL for inserting in the eyes during the cataract surgery
TECNIS Symfony ZXR00 intraocular lenDevice
In this study, we select TECNIS Symfony ZXR00 IOL for inserting in the eyes during the cataract surgery
ZEISS AT LISA tri 839MP intraocular lenDevice
In this study, we select ZEISS AT LISA tri 839MP IOL for inserting in the eyes during the cataract surgery
Primary outcomes
What the sponsor says the trial is designed to measure.
- Postoperative visual acuityTime frame: 3 months
- Postoperative contrast sensitivityTime frame: 3 months
- Postoperative defocus curveTime frame: 3 months
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Shanghai 10th People's Hospital
Shanghai, Shanghai Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.